MedPath
HSA Approval

BEPRAZ GASTRO RESISTANT TABLETS 20MG

SIN15259P

BEPRAZ GASTRO RESISTANT TABLETS 20MG

BEPRAZ GASTRO RESISTANT TABLETS 20MG

June 7, 2017

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRANBAXY (MALAYSIA) SDN. BHD.
Licence HolderRANBAXY (MALAYSIA) SDN. BHD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, DELAYED RELEASE

ORAL

Medical Information

A02BC04

rabeprazole

Manufacturer Information

RANBAXY (MALAYSIA) SDN. BHD.

Sun Pharmaceutical Industries Limited

Active Ingredients

Rabeprazole free base 18.85mg eqv Rabeprazole Sodium

20mg

Rabeprazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.